X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3332) 3332
Book Review (625) 625
Publication (208) 208
Conference Proceeding (23) 23
Book Chapter (5) 5
Web Resource (3) 3
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2625) 2625
humans (2453) 2453
oncology (2342) 2342
radiotherapy (1845) 1845
female (1839) 1839
middle aged (1605) 1605
chemotherapy (1530) 1530
aged (1496) 1496
cancer (1456) 1456
male (1329) 1329
adult (1248) 1248
radiation-therapy (1081) 1081
concurrent chemotherapy (942) 942
concurrent chemoradiotherapy (913) 913
care and treatment (908) 908
treatment outcome (859) 859
chemoradiotherapy (813) 813
neoplasm staging (791) 791
cisplatin (774) 774
combined modality therapy (763) 763
surgery (753) 753
radiology, nuclear medicine & medical imaging (740) 740
chemoradiation (720) 720
squamous-cell carcinoma (706) 706
carcinoma (686) 686
retrospective studies (653) 653
antineoplastic combined chemotherapy protocols - therapeutic use (635) 635
aged, 80 and over (595) 595
radiation (572) 572
survival (550) 550
radiation therapy (527) 527
hematology, oncology and palliative medicine (525) 525
concurrent chemoradiation (508) 508
cervical cancer (493) 493
cisplatin - administration & dosage (460) 460
prognosis (460) 460
disease-free survival (451) 451
radiotherapy dosage (436) 436
survival rate (435) 435
randomized-trial (427) 427
research (411) 411
induction chemotherapy (407) 407
toxicity (398) 398
analysis (391) 391
patients (390) 390
carcinoma, squamous cell - radiotherapy (376) 376
squamous cell carcinoma (373) 373
carcinoma, squamous cell - pathology (372) 372
survival analysis (372) 372
therapy (372) 372
follow-up studies (368) 368
trial (359) 359
medicine & public health (357) 357
carcinoma, squamous cell - therapy (345) 345
concurrent (344) 344
head and neck cancer (321) 321
carcinoma, squamous cell - drug therapy (319) 319
lung neoplasms - radiotherapy (298) 298
health aspects (295) 295
antineoplastic agents - therapeutic use (293) 293
uterine cervical neoplasms - pathology (287) 287
carcinoma, squamous cell - mortality (283) 283
neck-cancer (282) 282
otorhinolaryngology (279) 279
locally advanced head (271) 271
lung neoplasms - pathology (269) 269
intensity-modulated radiotherapy (266) 266
chemoradiotherapy - methods (259) 259
cancer therapies (256) 256
carcinoma, non-small-cell lung - radiotherapy (256) 256
lung cancer, non-small cell (253) 253
patient outcomes (253) 253
phase-iii (250) 250
uterine cervical neoplasms - radiotherapy (245) 245
carcinoma, non-small-cell lung - pathology (242) 242
radiology (237) 237
phase-iii trial (236) 236
fluorouracil - administration & dosage (235) 235
head and neck neoplasms - radiotherapy (232) 232
lung cancer (232) 232
lung neoplasms - drug therapy (225) 225
neoadjuvant therapy (225) 225
obstetrics & gynecology (225) 225
chemotherapy, adjuvant (223) 223
phase-ii trial (221) 221
esophageal cancer (220) 220
risk factors (216) 216
head and neck neoplasms - drug therapy (209) 209
gynecologic-oncology-group (208) 208
respiratory system (207) 207
phase-ii (205) 205
tumors (205) 205
uterine cervical neoplasms - drug therapy (204) 204
antineoplastic combined chemotherapy protocols - adverse effects (202) 202
carcinoma, non-small-cell lung - drug therapy (202) 202
uterine cervical neoplasms - therapy (202) 202
cancer patients (196) 196
kaplan-meier estimate (195) 195
chemoradiotherapy - adverse effects (194) 194
lung neoplasms - therapy (193) 193
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3259) 3259
French (36) 36
Korean (31) 31
Japanese (13) 13
German (11) 11
Spanish (4) 4
Polish (3) 3
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 5, pp. 1099 - 1107
Purpose To quantify the relationship between bone marrow (BM) response to radiation and radiation dose by using18 F-labeled fluorodeoxyglucose positron... 
Radiology | Hematology, Oncology and Palliative Medicine | CONSENSUS GUIDELINES | DELINEATION | GYNECOLOGIC MALIGNANCIES | CLINICAL TARGET VOLUME | ONCOLOGY | CONCURRENT CHEMOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | PELVIC RADIOTHERAPY | EMISSION-TOMOGRAPHY | PARAMETERS | COMPARTMENT | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Fluorodeoxyglucose F18 - pharmacokinetics | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Bone Marrow - radiation effects | Carcinoma, Squamous Cell - diagnostic imaging | Bone Marrow Cells - diagnostic imaging | Cisplatin - administration & dosage | Multimodal Imaging | Radiation-Sensitizing Agents - administration & dosage | Bone Marrow - metabolism | Aged, 80 and over | Adult | Female | Bone Marrow - diagnostic imaging | Retrospective Studies | Uterine Cervical Neoplasms - therapy | Radiotherapy Dosage | Acute Disease | Chemoradiotherapy - methods | Radiopharmaceuticals - pharmacokinetics | Radiotherapy, Intensity-Modulated - methods | Carcinoma, Squamous Cell - therapy | Bone Marrow Cells - radiation effects | Positron-Emission Tomography - methods | Blood Cell Count | Regression Analysis | Adenocarcinoma - therapy | Uterine Cervical Neoplasms - diagnostic imaging | Aged | Adenocarcinoma - diagnostic imaging | Bone Marrow Cells - metabolism | Cancer patients | Care and treatment | PET imaging | Radiation | Sport-utility vehicles | Standards | Cervical cancer | Cancer | Index Medicus | DIAGNOSIS | PATIENTS | NEOPLASMS | FLUORODEOXYGLUCOSE | BONE MARROW | RADIATION DOSES | TOXICITY | SKELETON | POSITRON COMPUTED TOMOGRAPHY | UPTAKE | RADIOLOGY AND NUCLEAR MEDICINE | BLOOD CELLS | RADIOTHERAPY | FLUORINE 18
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 1, pp. 228 - 239
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 70, Issue 5, pp. 1382 - 1388
Purpose To attempt to improve results of chemoradiation for head and neck cancer. Methods and Materials From March 1996 to April 2007, 98 patients with head... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Carbogen | Chemoradiation | Hyperfractionation | hyperfractionation | head and neck cancer | OXYGENATION | ACCELERATED RADIOTHERAPY | OROPHARYNGEAL CARCINOMA | TONSILLAR CARCINOMA | CHEMOTHERAPY | RADIATION-THERAPY | RANDOMIZED TRIAL | CONVENTIONAL FRACTIONATION | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | CONCURRENT CHEMORADIATION | chemoradiation | carbogen | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Follow-Up Studies | Erythropoietin - therapeutic use | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Clinical Protocols | Salvage Therapy | Carbon Dioxide - administration & dosage | Male | Antineoplastic Agents - therapeutic use | Recombinant Proteins | Carcinoma, Squamous Cell - radiotherapy | Anemia - drug therapy | Carcinoma, Squamous Cell - mortality | Radiation-Sensitizing Agents - administration & dosage | Adult | Dose Fractionation | Female | Head and Neck Neoplasms - drug therapy | Administration, Inhalation | Carboplatin - administration & dosage | Head and Neck Neoplasms - pathology | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Oxygen - administration & dosage | Carcinoma, Squamous Cell - drug therapy | Radiation Injuries - pathology | Aged | Combined Modality Therapy - methods | Head and Neck Neoplasms - mortality | Neoplasm Staging | Index Medicus | HEAD | PATIENTS | ERYTHROPOIETIN | NEOPLASMS | RADIATION DOSES | TOXICITY | IRRADIATION | RESPIRATION | RADIOLOGY AND NUCLEAR MEDICINE | ANEMIAS | NECK | RADIOTHERAPY
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 09/2016, Volume 108, Issue 9
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 93, Issue 5, pp. 976 - 985
Purpose To perform a prospective, multi-institutional, phase 2 study of a substantial decrease in concurrent chemoradiation therapy (CRT) intensity as primary... 
Radiology | Hematology, Oncology and Palliative Medicine | WEEKLY CISPLATIN | LATE TOXICITY | ONCOLOGY | POSITIVE HEAD | RANDOMIZED-TRIAL | LOCALLY ADVANCED HEAD | QUALITY-OF-LIFE | EUROPEAN-ORGANIZATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | NECK-CANCER | CONCURRENT CHEMORADIOTHERAPY | RADIATION-THERAPY | Lymph Node Excision | Oropharyngeal Neoplasms - therapy | Chemoradiotherapy - adverse effects | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Antineoplastic Agents - administration & dosage | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Cyclin-Dependent Kinase Inhibitor p16 | Stomatitis - pathology | Adult | Female | Radiotherapy Dosage | Chemoradiotherapy - methods | Papillomavirus Infections - complications | Radiotherapy, Intensity-Modulated - methods | Carcinoma, Squamous Cell - therapy | Carcinoma, Squamous Cell - chemistry | Treatment Outcome | Oropharyngeal Neoplasms - virology | Stomatitis - etiology | Biopsy | Smoking - epidemiology | Neoplasm Proteins - analysis | Oropharyngeal Neoplasms - chemistry | Papillomaviridae | Aged | Patient Compliance | Papillomaviruses | Sects | Medical colleges | Care and treatment | Squamous cell carcinoma | Clinical trials | Papillomavirus infections | Index Medicus | LYMPH NODES | RADIATION HAZARDS | RADIOLOGY AND NUCLEAR MEDICINE | TOXICITY | RADIOTHERAPY | GY RANGE 10-100 | CHEMOTHERAPY
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 94, Issue 4, pp. 747 - 754
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 425 - 434
Purpose Patients treated with chemoradiotherapy for locally advanced non–small-cell lung carcinoma (LA-NSCLC) were analyzed for local-regional failure (LRF)... 
Radiology | Hematology, Oncology and Palliative Medicine | Survival with respect to radiotherapy dose intensity | Local-regional failure | Radiation oncology | Chemoradiotherapy | Advanced non–small-cell lung carcinoma | Advanced non-small-cell lung carcinoma | LEUKEMIA GROUP-B | INDUCTION CHEMOTHERAPY | CONSOLIDATION DOCETAXEL | COMPETING RISK | FOLLOW-UP | CANCER | PHASE-III TRIAL | ONCOLOGY | HYPERFRACTIONATED RADIATION | CONCURRENT CHEMORADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | THORACIC RADIOTHERAPY | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Treatment Failure | Aged, 80 and over | Adult | Female | Retrospective Studies | Paclitaxel - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Chemoradiotherapy - methods | Proportional Hazards Models | Carboplatin - administration & dosage | Etoposide - administration & dosage | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Amifostine - administration & dosage | Aged | Relative Biological Effectiveness | Medical colleges | Care and treatment | Carcinoma | Nuclear radiation | Patient outcomes | Lung cancer, Non-small cell | Radiotherapy | Cancer | Statistical analysis | Lung | Radiation | Clinical trials | Non-small cell lung carcinoma | Data processing | Dose-response effects | Oncology | Radiation therapy | Multivariate analysis | Survival | Index Medicus | MULTIVARIATE ANALYSIS | PATIENTS | TESTING | FAILURES | LUNGS | CARCINOMAS | STANDARDS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | RADIOTHERAPY | COMBINED THERAPY | HAZARDS | chemoradiotherapy | local-regional failure | Radiation Oncology | advanced non-small-cell lung carcinoma | survival with respect to radiotherapy dose intensity
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 97, Issue 4, pp. 786 - 796
Journal Article